MedPage Today Meeting CoverageThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. Subscribe to this data using MyMedWorm.Subscribe to this data using GoogleReader.Subscribe to this data using Bloglines.Subscribe to this data using MyYahoo.

This page shows you the latest items in this publication.

Pages: 1 2 3 4 5

222 records returned

ESSM: Flibanserin Boosts Sex Life of Low-Libido Women (CME/CE, with video)Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
The investigational drug flibanserin looks like an effective treatment to increase sexual interest and satisfaction in women with hypoactive sexual desire disorder, researchers said. (Source: MedPage Today Meeting Coverage)
Source: MedPage Today Meeting Coverage - November 16, 2009 Category: Journals (General) Source Type: info

AHA: Program Chair Previews Meeting and MoreEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
ORLANDO (MedPage Today) -- In this exclusive MedPage Today InFocus™ video report, Mariell Jessup, MD, program chair for the American Heart Association annual meeting, previews the sessions ahead and discusses the challenges that face the AHA as the nation moves toward healthcare reform. (Source: MedPage Today Meeting Coverage)
Source: MedPage Today Meeting Coverage - November 14, 2009 Category: Journals (General) Source Type: info

CHEST: Uncertainty Surrounds Opioids in Advanced COPD (CME/CE)Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
SAN DIEGO (MedPage Today) -- Patients with advanced chronic obstructive pulmonary disease (COPD) may not be getting effective treatment for dyspnea toward the end of life, researchers reported here. (Source: MedPage Today Meeting Coverage)
Source: MedPage Today Meeting Coverage - November 6, 2009 Category: Journals (General) Source Type: info

CHEST: COPD Treatment Determines Risk of Hospitalization (CME/CE)Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
SAN DIEGO (MedPage Today) -- For patients with chronic obstructive pulmonary disease (COPD), the likelihood of being hospitalized appears to vary depending on the type of long-acting bronchodilator treatment they're receiving, a retrospective study showed. (Source: MedPage Today Meeting Coverage)
Source: MedPage Today Meeting Coverage - November 6, 2009 Category: Journals (General) Source Type: info

CHEST: Novel LABA Improves Lung Function in COPD (CME/CE)Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
SAN DIEGO (MedPage Today) -- Indacaterol, an investigational long-acting beta2-agonist, showed benefits over both placebo and salmeterol (Serevent) for moderate-to-severe chronic obstructive pulmonary disease (COPD) in a randomized trial, researchers reported here. (Source: MedPage Today Meeting Coverage)
Source: MedPage Today Meeting Coverage - November 5, 2009 Category: Journals (General) Source Type: info

CHEST: Varenicline Helps Patients with COPD Quit Smoking (CME/CE, with video)Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
SAN DIEGO (MedPage Today) -- Much as it aided the general population of smokers, varenicline (Chantix) helped patients with chronic obstructive pulmonary disorder (COPD) quit too, a randomized trial showed. (Source: MedPage Today Meeting Coverage)
Source: MedPage Today Meeting Coverage - November 4, 2009 Category: Journals (General) Source Type: info

ASN: Heavy Burden from CKD-Related Anemia in Patients with Diabetes (CME/CE)Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
SAN DIEGO (MedPage Today) -- Patients with type 2 diabetes and anemia related to nondialysis chronic kidney disease have significant impairment in quality of life, two surveys showed. (Source: MedPage Today Meeting Coverage)
Source: MedPage Today Meeting Coverage - November 4, 2009 Category: Journals (General) Source Type: info

ASN: Hyperuricemia Treatment May Save Infants' Kidneys (CME/CE)Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
SAN DIEGO (MedPage Today) -- Hyperuricemia occurring in infants with acute kidney injury was effectively treated with a single dose of the recombinant urate oxidase (rasburicase) according to findings reported here. (Source: MedPage Today Meeting Coverage)
Source: MedPage Today Meeting Coverage - November 4, 2009 Category: Journals (General) Source Type: info

CHEST: No Sex Difference Found in COPD Treatment (CME/CE)Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
SAN DIEGO (MedPage Today) -- Men and women with chronic obstructive pulmonary disorder (COPD) derive comparable benefits from treatment with tiotropium (Spiriva), researchers found. (Source: MedPage Today Meeting Coverage)
Source: MedPage Today Meeting Coverage - November 4, 2009 Category: Journals (General) Source Type: info

AASLD: Antibiotics Top Cause of Drug-Induced Liver Failure (CME/CE)Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
BOSTON (MedPage Today) -- Antimicrobial agents are the most common cause of drug-induced liver failure, with most cases ending in death or transplant, a researcher said here. (Source: MedPage Today Meeting Coverage)
Source: MedPage Today Meeting Coverage - November 4, 2009 Category: Journals (General) Source Type: info

ASN: Major Anemia Trial Results Lead to Practice Changes (CME/CE)Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
SAN DIEGO (MedPage Today) -- Clinicians heeded the warnings of two major studies and subsequent regulatory action when using erythropoiesis-stimulating agents (ESAs) to treat anemia in patients with chronic kidney disease, a single-center study showed. (Source: MedPage Today Meeting Coverage)
Source: MedPage Today Meeting Coverage - November 3, 2009 Category: Journals (General) Source Type: info

ASN: Nighttime Dialysis May Boost Sensitivity to Anemia Agents (CME/CE)Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
SAN DIEGO (MedPage Today) -- Doubling the time spent on dialysis by doing it while patients are sleeping is associated with increased sensitivity to treatments for anemia, researchers found. (Source: MedPage Today Meeting Coverage)
Source: MedPage Today Meeting Coverage - November 3, 2009 Category: Journals (General) Source Type: info

ASN: No CVD Benefit for Folic Acid in Kidney Transplant (CME/CE)Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
SAN DIEGO (MedPage Today) -- Lowering homocysteine levels with folic acid supplementation yielded no cardiovascular benefit for stable renal transplant recipients, a randomized trial showed. (Source: MedPage Today Meeting Coverage)
Source: MedPage Today Meeting Coverage - November 3, 2009 Category: Journals (General) Source Type: info

CHEST: Anemia Prevalent in COPD (CME/CE)Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
SAN DIEGO (MedPage Today) -- Anemia is a significant comorbidity in patients with chronic obstructive pulmonary disease (COPD), a retrospective study showed. (Source: MedPage Today Meeting Coverage)
Source: MedPage Today Meeting Coverage - November 3, 2009 Category: Journals (General) Source Type: info

ASN: Febuxostat Works in Gout Patients with Renal Impairment (CME/CE)Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
SAN DIEGO (MedPage Today) -- In patients with gout and preexisting mild to moderate renal impairment, febuxostat (Uloric) is more effective and as safe as allopurinol, the gold standard gout treatment, researchers found. (Source: MedPage Today Meeting Coverage)
Source: MedPage Today Meeting Coverage - November 2, 2009 Category: Journals (General) Source Type: info

ASN: Regular Soda Not to Blame for Hyperuricemia (CME/CE)Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
SAN DIEGO (MedPage Today) -- Drinking regular soda is not associated with the development of hyperuricemia or chronic kidney disease, a large epidemiological study showed. (Source: MedPage Today Meeting Coverage)
Source: MedPage Today Meeting Coverage - November 2, 2009 Category: Journals (General) Source Type: info

AAO: Dual Optic Lens Shines (CME/CE)Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
SAN FRANCISCO (MedPage Today) -- A novel "dual optic" accommodating intraocular lens improved intermediate distance vision and contrast sensitivity under low light conditions compared with some multifocal lenses, researchers said. (Source: MedPage Today Meeting Coverage)
Source: MedPage Today Meeting Coverage - November 2, 2009 Category: Journals (General) Source Type: info

AAO: Femtosecond Lasers Promising for Safer Cataract Surgery (CME/CE, with video)Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
SAN FRANCISCO (MedPage Today) -- Femtosecond-pulse lasers like those used for LASIK may be poised to take over from manual incision and phacoemulsification in cataract surgery as well, leading eye surgeons said. (Source: MedPage Today Meeting Coverage)
Source: MedPage Today Meeting Coverage - October 30, 2009 Category: Journals (General) Source Type: info

AAO: Less Invasive Treatment Stops Ectasia Progression (CME/CE)Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
SAN FRANCISCO (MedPage Today) -- An experimental treatment to crosslink proteins in the cornea can halt destabilizing complications after refractive surgery long term, researchers found. (Source: MedPage Today Meeting Coverage)
Source: MedPage Today Meeting Coverage - October 29, 2009 Category: Journals (General) Source Type: info

AAO: Photodynamic Therapy No Help in Treating Macular Degeneration (CME/CE)Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
SAN FRANCISCO (MedPage Today) -- Photodynamic therapy doesn't add to the effectiveness of standard treatment of wet age-related macular degeneration or decrease the need for intravitreal injections, researchers said. (Source: MedPage Today Meeting Coverage)
Source: MedPage Today Meeting Coverage - October 29, 2009 Category: Journals (General) Source Type: info

ACR: Allopurinol Sensitivity More Likely in Patients with Renal Problems (CME/CE)Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
PHILADELPHIA (MedPage Today) -- Hypersensitivity to the anti-uricemic drug allopurinol, often leading to acute kidney failure, is up to three times as common in patients who already suffer renal impairment, according to research presented here. (Source: MedPage Today Meeting Coverage)
Source: MedPage Today Meeting Coverage - October 28, 2009 Category: Journals (General) Source Type: info

AAO: Higher-Dose Injection No Better for Retinal Vein Occlusion (CME/CE, with video)Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
SAN FRANCISCO (MedPage Today) -- Increasing the dose of intravitreal bevacizumab (Avastin) doesn't improve outcomes for central retinal vein occlusion, researchers found. (Source: MedPage Today Meeting Coverage)
Source: MedPage Today Meeting Coverage - October 28, 2009 Category: Journals (General) Source Type: info

ACR: Gout and Metabolic Disease Go Hand in Hand (CME/CE)Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
PHILADELPHIA (MedPage Today) -- Gout and hyperuricemia may represent another facet of metabolic syndrome, so closely tied are they to obesity, high cholesterol, and type 2 diabetes, suggested several studies presented here. (Source: MedPage Today Meeting Coverage)
Source: MedPage Today Meeting Coverage - October 27, 2009 Category: Journals (General) Source Type: info

AAO: Intravitreal Shots Carry Risk of Persistent Glaucoma (CME/CE, with video)Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
SAN FRANCISCO (MedPage Today) -- Intravitreal injections of vascular endothelial growth factor (VEGF) inhibitors can cause persistent hypertension in the eye after only one treatment, researchers found. (Source: MedPage Today Meeting Coverage)
Source: MedPage Today Meeting Coverage - October 27, 2009 Category: Journals (General) Source Type: info

AAO: Genes Linked to Response in Macular Degeneration (CME/CE)Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
SAN FRANCISCO (MedPage Today) -- Genes may predict response to ranibizumab (Lucentis) for patients with neovascular age-related macular degeneration, according to a genome-wide association study. (Source: MedPage Today Meeting Coverage)
Source: MedPage Today Meeting Coverage - October 27, 2009 Category: Journals (General) Source Type: info

AAO: Gene Therapy Restores Partial Vision (CME/CE)Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
SAN FRANCISCO (MedPage Today) -- Gene therapy to counteract retinal degeneration from a rare inherited sight disorder improved vision in all patients, including one child who recovered nearly normal light sensitivity. (Source: MedPage Today Meeting Coverage)
Source: MedPage Today Meeting Coverage - October 24, 2009 Category: Journals (General) Source Type: info

ACR: Pump Up the Allopurinol to Prevent Gout (CME/CE)Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
PHILADELPHIA (MedPage Today) -- Going beyond the recommended dosing of allopurinol (Zyloprim) to treat patients with gout may help prevent recurrence safely, researchers contended here. (Source: MedPage Today Meeting Coverage)
Source: MedPage Today Meeting Coverage - October 23, 2009 Category: Journals (General) Source Type: info

ACR: Drinking Water May Wash Away Gout Attacks (CME/CE)Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
PHILADELPHIA (MedPage Today) -- A half-gallon of drinking water a day may keep gout attacks away, researchers said here. (Source: MedPage Today Meeting Coverage)
Source: MedPage Today Meeting Coverage - October 21, 2009 Category: Journals (General) Source Type: info

ACR: Video Gaming Linked to Joint Pain, Especially in Kids (CME/CE)Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
PHILADELPHIA (MedPage Today) -- In a study launched by the curiosity of an 11-year-old, playing video games was associated with finger and wrist pain among children at a St. Louis elementary school, researchers reported here. (Source: MedPage Today Meeting Coverage)
Source: MedPage Today Meeting Coverage - October 21, 2009 Category: Journals (General) Source Type: info

AAP: Prescription and OTC Drugs Use on the Rise (CME/CE)Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
WASHINGTON (MedPage Today) -- While use of illegal drugs among adolescents has declined in recent years, an increasing number of teens are abusing prescription and over-the-counter drugs, according to a pediatrician here. (Source: MedPage Today Meeting Coverage)
Source: MedPage Today Meeting Coverage - October 21, 2009 Category: Journals (General) Source Type: info

ACR: Low-Dose Colchicine Cuts Gout Pain in a Day (CME/CE)Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
PHILADELPHIA (MedPage Today) -- Low-dose colchicine (Colcrys) appears to be as effective as high doses of the drug in reducing the pain of gout with fewer adverse side effects, a researcher said here. (Source: MedPage Today Meeting Coverage)
Source: MedPage Today Meeting Coverage - October 21, 2009 Category: Journals (General) Source Type: info

ACR: Skim Milk Might Prevent Gout (CME/CE)Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
PHILADELPHIA (MedPage Today) -- Drinking fat-free milk may reduce men's risk of gout, researchers suggested here. (Source: MedPage Today Meeting Coverage)
Source: MedPage Today Meeting Coverage - October 20, 2009 Category: Journals (General) Source Type: info

ACR: Rituximab Equals Standard Treatment for Vasculitis (CME/CE)Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
PHILADELPHIA (MedPage Today) -- Rituximab (Rituxan) and cyclophosphamide were equally effective in inducing remission in patients with severe ANCA-associated vasculitis, researchers reported here. (Source: MedPage Today Meeting Coverage)
Source: MedPage Today Meeting Coverage - October 20, 2009 Category: Journals (General) Source Type: info

ACR: Monoclonal Antibody Reduces Lupus Activity (CME/CE, with video)Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
PHILADELPHIA (MedPage Today) -- The investigational monoclonal antibody belimumab (Benlysta) was safe and effective for patients with systemic lupus erythematosus in a Phase III trial. (Source: MedPage Today Meeting Coverage)
Source: MedPage Today Meeting Coverage - October 20, 2009 Category: Journals (General) Source Type: info

ACR: Monoclonal Antibody Reduces Lupus Activity (CME/CE)Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
PHILADELPHIA (MedPage Today) -- The investigational monoclonal antibody belimumab (Benlysta) was safe and effective for patients with systemic lupus erythematosus in a Phase III trial. (Source: MedPage Today Meeting Coverage)
Source: MedPage Today Meeting Coverage - October 20, 2009 Category: Journals (General) Source Type: info

AAP: DHA Important in Infant Brain DevelopmentEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Fat is the most essential nutrient in a young infant's diet (MedPage Today) -- particularly the long-chain docosahexaenoic acid (DHA), researchers said in Washington. (Source: MedPage Today Meeting Coverage)
Source: MedPage Today Meeting Coverage - October 19, 2009 Category: Journals (General) Source Type: info

AAP: Docs Advised to Learn About Kids' Media Use (CME/CE)Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Music, movies, television, and video games can have adverse effects on the behavior of children and teens, so doctors should find out what their young patients watch and listen to, according to two policy statements from the American Academy of Pediatrics. (Source: MedPage Today Meeting Coverage)
Source: MedPage Today Meeting Coverage - October 19, 2009 Category: Journals (General) Source Type: info

AAP: Safety Benefits of Booster Seats Reaffirmed (CME/CE)Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Children ages 4 to 8 are safer using booster seats than seatbelts alone when riding in cars, new research confirmed. (Source: MedPage Today Meeting Coverage)
Source: MedPage Today Meeting Coverage - October 19, 2009 Category: Journals (General) Source Type: info

ANA: No Benefit for Quinacrine in CJD (CME/CE)Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
BALTIMORE (MedPage Today) -- The first U.S. treatment trial for sporadic Creutzfeldt-Jakob disease (CJD) has shown that quinacrine does not extend survival compared with placebo. (Source: MedPage Today Meeting Coverage)
Source: MedPage Today Meeting Coverage - October 15, 2009 Category: Journals (General) Source Type: info

ANA: Agent Reduces Seizures as Add-on Epilepsy Therapy (CME/CE)Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
BALTIMORE (MedPage Today) -- Eslicarbazepine acetate (Stedesa), a European anti-epileptic drug not yet licensed in the U.S., reduced seizure frequency and was well tolerated as an add-on treatment in patients with refractory partial-onset seizures in a trial reported here. (Source: MedPage Today Meeting Coverage)
Source: MedPage Today Meeting Coverage - October 13, 2009 Category: Journals (General) Source Type: info

AAO: Top-Down Cruising May Harm Hearing (CME/CE)Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
SAN DIEGO (MedPage Today) -- Cruising down the highway in a sleek convertible, with the wind blowing in your hair, may sound like the ideal road trip -- but it could harm your hearing, British scientists said. (Source: MedPage Today Meeting Coverage)
Source: MedPage Today Meeting Coverage - October 7, 2009 Category: Journals (General) Source Type: info

More Patients with Chronic Disease OK to Dive (CME/CE)Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
NEW BRUNSWICK, N.J. (MedPage Today) -- An increasing number of patients with controlled diabetes, asthma, and other diseases are getting the green light for an activity that was once off limits: scuba diving. (Source: MedPage Today Meeting Coverage)
Source: MedPage Today Meeting Coverage - October 7, 2009 Category: Journals (General) Source Type: info

Angiogenesis Inhibitor Works in Macular Edema (CME/CE)Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Patients with macular edema related to retinal vein occlusion had significant improvement in vision when treated with ranibizumab (Lucentis) in each of two dosages, randomized clinical trials showed. (Source: MedPage Today Meeting Coverage)
Source: MedPage Today Meeting Coverage - October 6, 2009 Category: Journals (General) Source Type: info

TCT: Studies Lift Everolimus Stent to Head of Class (CME/CE)Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
SAN FRANCISCO (MedPage Today) -- A pair of trials comparing the everolimus-eluting Xience stent to the paclitaxel-eluting Taxus stent appears to provide compelling evidence of Xience's superiority. (Source: MedPage Today Meeting Coverage)
Source: MedPage Today Meeting Coverage - September 24, 2009 Category: Journals (General) Source Type: info

ASBMR: New Reference Values Set to Gauge Obesity (CME/CE, with video)Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
DENVER (MedPage Today) -- Normal values for 10 body composition parameters -- including a proposed replacement for body mass index (BMI) -- have been established from NHANES data. (Source: MedPage Today Meeting Coverage)
Source: MedPage Today Meeting Coverage - September 21, 2009 Category: Journals (General) Source Type: info

ASBMR: New Reference Values Set to Gauge Obesity (CME/CE)Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
DENVER (MedPage Today) -- Normal values for 10 body composition parameters -- including a proposed replacement for body mass index (BMI) -- have been established from NHANES data. (Source: MedPage Today Meeting Coverage)
Source: MedPage Today Meeting Coverage - September 21, 2009 Category: Journals (General) Source Type: info

PRC: Funding Influences Conflict of Interest Best Practices (CME/CE)Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
VANCOUVER (MedPage Today) -- Few investigators say they always follow best practices in order to mitigate financial conflict of interest in their trials -- especially when they're funded by industry, researchers here said. (Source: MedPage Today Meeting Coverage)
Source: MedPage Today Meeting Coverage - September 11, 2009 Category: Journals (General) Source Type: info

PRC: Study Finds Less Ghost Authorship, Critics Ask Why (CME/CE)Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
VANCOUVER (MedPage Today) -- The practice of ghostwriting in major medical journals has declined since the mid-1990s, according to new study, but critics say the drop could be the result of authors' unwillingness to admit the practice. (Source: MedPage Today Meeting Coverage)
Source: MedPage Today Meeting Coverage - September 11, 2009 Category: Journals (General) Source Type: info

ESC: SYNTAX Still Gives Edge to CABG (CME/CE)Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
BARCELONA (MedPage Today) -- Two-year data from the 1,800-patient SYNTAX trial essentially confirmed the edge given a year ago to coronary artery bypass grafting over stenting to treat complex coronary lesions, researchers said here. (Source: MedPage Today Meeting Coverage)
Source: MedPage Today Meeting Coverage - September 2, 2009 Category: Journals (General) Source Type: info

ESC: Prevention Strategy Relies on Lifestyle, GeneticsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
BARCELONA (MedPage Today) -- Stenting may not always be the answer to treating acute heart disease, German researchers say. (Source: MedPage Today Meeting Coverage)
Source: MedPage Today Meeting Coverage - August 30, 2009 Category: Journals (General) Source Type: info